Founded by seasoned entrepreneurs

PreComb therapeutics AG was founded in 2018 by two experienced serial Entrepreneurs. Their accumulated and complementory expertises range from cell culture technology, product development, data management, biopharmaceutical development & production and clinical trial supply. From their past leadership roles in InSphero AG and ESBATech, both founders bring in a wealth of experices in technology development, personnel development, company build-up and maturation.

Founders at a glance

  • More than 20 years in biotech and pharma
  • 3 biotech companies founded
  • 15 years of expertise in 3D tissue models
  • >50 publications & 9 patents published
  • Process development of BEOVU®
Jens M. Kelm, CEO of PreComb

Jens M. Kelm, PhD

Co-Founder & CEO

Formerly, CSO and CTO at InSphero AG (co-founder) developing physiological 3D models, assays and screening concepts. Holds >50 publications and 9 Patents; Formerly member of the Board of InSphero, co-founder and steering committee member of the competence center for Tissue Engineering and Drug Development (TEDD). Jens holds a PhD in Biology (Cell biology) from the ETH Zürich.

Peter Steiner, PhD

Co-founder, COO and president of the board​

Formerly, Executive Director and Head of the Production & Processes department of ESBATech, a Novartis company. Responsible for manufacturing process development of BEOVU® (Brolucizumab, Novartis) and other drug candidates successfully tested in clinical POC trials. Co-founder and member of the board of Insilico Biotechnology AG. Peter holds a PhD in Biology (Biotechnology) from the ETH Zürich.

Peter Steiner, COO of PreComb
Close Menu